Sign inJoin waitlistJoin the waitlist

Richard S. Finn

Directing the Translational Research Laboratory

Credentials: · · · ·

History

Geffen School of Medicine at UCLA
Present

UCLA School of Medicine
Until 2003
UCLA School of Medicine
Until 2000
UCLA School of Medicine
Until 1998
Keck School of Medicine of the USC
1997
UCLA

Research

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
New England Journal of Medicine · 2020 · First of 22 authors · 6,239 citations
Hepatocellular carcinoma
Review · Nature Reviews Disease Primers · 2021 · Last of 10 authors · 5,588 citations
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
The Lancet · 2018 · 4,649 citations

Dennis Slamon
42 papers
AZ
Andrew Zhu
41 papers
Hope Rugo
24 papers
Ronald Busuttil
22 papers
Vatche Agopian
18 papers
AS
Abby Siegel
17 papers
Saeed Sadeghi
16 papers
Kate Kelley
14 papers
Massimo Cristofanilli
11 papers
Amit Singal
10 papers
PA
Paolo Abada
10 papers
RL
Riccardo Lencioni
10 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $874.2K · University of California Los Angeles
1996–2030

Clinical trials

A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
Principal investigator · Not yet recruiting · Phase 2
Akeso
2025–2027
AFPᶜ³³²T in Advanced HCC
Principal investigator · Completed · Phase 1
Adaptimmune
2017–2025
Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone
Study chair · Terminated · Phase 2
Translational Research in Oncology
2014–2018
Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer
Study chair · Terminated · Phase 2
Translational Research in Oncology
2009–2010